Cantor Fitzgerald has a “Overweight” rating and a $790.00 price target on the stock. The consensus estimate for Meta Platforms’ current full-year earnings is $26.70 per share.

Bradmer Pharmaceuticals Inc. (TSE:GLX – Free Report) – Research analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for shares of Bradmer Pharmaceuticals in a note issued to ...

Cantor Fitzgerald assumed coverage of Aclaris Therapeutics (ACRS) with an Overweight rating. Cantor is bullish on the TSLP and IL-4R bispecific, which looks differentiated, and even early proof-of ...

On Tuesday, Cantor Fitzgerald released a new report on the semiconductor and semiconductor equipment sector, highlighting the current geopolitical challenges that are impacting the industry ...

On Thursday, Cantor Fitzgerald reaffirmed its positive stance on Alumis Inc (NASDAQ: ALMS), maintaining an Overweight rating on the company’s shares. The stock, currently trading at $4.37 ...

Cantor Fitzgerald upgraded Tesla (TSLA, Financials) to Overweight from Neutral, citing a buying opportunity following the recent sell-off, the firm announced after a site visit to Tesla's ...

Tesla (NASDAQ:TSLA) attracted an upgrade from Cantor Fitzgerald on Wednesday after the firm visited the company's Gigafactory and AI data centers in Austin. The firm moved Tesla (NASDAQ ...

Cantor Fitzgerald biotech analysts slammed the leadership of Health and Human Services Secretary Robert F. Kennedy Jr., calling on the Trump administration to “re-evaluate” his role after a ...

Investor uncertainty is at the heart of Wall Street’s sell-off, Cantor Fitzgerald stated, as markets are unsure about the current direction of the landscape it stands on with ongoing tariff ...

March 31 (Reuters) - Analysts at Cantor Fitzgerald, formerly headed by the Trump administration's Secretary of Commerce Howard Lutnick, called for the dismissal of Secretary of Health and Human ...

Fintel reports that on April 3, 2025, Cantor Fitzgerald upgraded their outlook for Zscaler (NasdaqGS:ZS) from Neutral to Overweight. As of April 1, 2025, the average one-year price target for ...